Answers are grounded in this paper and cite their sources.
Background Myeloid sarcoma (MS) is an exceptionally rare condition, with instances of predominantly cutaneous involvement in neonates being even more uncommon. The natural history varies from indolent regression to rapid systemic progression, making therapeutic decision-making challenging. Case presentation We describe two newborns with MS, who presented with small firm lesions at birth and subsequently developed generalized multiple erythematous lesions within weeks. Methods A systematic literature search was conducted on PubMed and Embase to evaluate the prognostic patterns of neonatal MS. Data from 13 cases with skin-limited involvement were synthesized. Results Among the 13 reviewed cases, spontaneous regression was documented in only 3 patients (23.1%). The majority (76.9%) required intensive therapy or had fatal outcomes. Conclusions This report provides an overview of neonatal MS, spontaneous regression of neonatal MS is a documented but rare phenomenon. A watchful waiting strategy remains high-risk and should be reserved only for strictly asymptomatic cases under continuous clinical surveillance.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: